BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34633770)

  • 1. Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus-like features.
    Giubellino A; Nelson AC; He Y; Munro SA; Song KY; Glitza Oliva IC; Torres-Cabala C
    Pigment Cell Melanoma Res; 2022 Mar; 35(2):229-237. PubMed ID: 34633770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deep penetrating nevus.
    Strazzula L; Senna MM; Yasuda M; Belazarian L
    J Am Acad Dermatol; 2014 Dec; 71(6):1234-40. PubMed ID: 25175710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
    Isales MC; Khan AU; Zhang B; Compres EV; Kim D; Tan TL; Beaubier N; Gerami P
    J Cutan Pathol; 2020 Dec; 47(12):1150-1154. PubMed ID: 32526042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
    de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
    Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus.
    Dunn ALJ; Gardner JM; Kaley JR; Bellamy W; Shalin SC
    Am J Dermatopathol; 2018 Jul; 40(7):469-478. PubMed ID: 29923908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and Atypical Deep Penetrating Nevus, Deep Penetrating Nevus-like Melanoma, and Related Variants.
    Gill P; Aung PP
    Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Atypical Deep Penetrating Nevus With Mutations in Beta Catenin , BRAFV600E , and IDH1R132C in an 8-Year-Old Boy.
    Ireland AM; Wood BA; Whitfield J; Amanuel B; Harvey NT; Mesbah Ardakani N
    Am J Dermatopathol; 2022 Aug; 44(8):607-610. PubMed ID: 35385855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus?
    High WA; Alanen KW; Golitz LE
    J Am Acad Dermatol; 2006 Sep; 55(3):460-6. PubMed ID: 16908352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions.
    Zhou Y; Nelson AC; He Y; Munro SA; Song KY; Domingo-Musibay E; Giubellino A
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep penetrating nevus.
    Seab JA; Graham JH; Helwig EB
    Am J Surg Pathol; 1989 Jan; 13(1):39-44. PubMed ID: 2909196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK.
    Oulès B; Mourah S; Baroudjian B; Jouenne F; Delyon J; Louveau B; Gruber A; Lebbé C; Battistella M
    Virchows Arch; 2022 Feb; 480(2):475-480. PubMed ID: 34013383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
    Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
    Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epithelioid and hyperpigmented melanocytic tumors. An overview].
    Kutzner H; Schärer L; Requena L
    Pathologe; 2007 Nov; 28(6):411-21. PubMed ID: 17899087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation.
    Kline N; Menge TD; Hrycaj SM; Andea AA; Patel RM; Harms PW; Chan MP; Bresler SC
    Am J Dermatopathol; 2022 Jun; 44(6):404-410. PubMed ID: 34991102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases.
    Ball NJ; Golitz LE
    J Am Acad Dermatol; 1994 May; 30(5 Pt 1):724-9. PubMed ID: 8176011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus.
    Cooper PH
    J Cutan Pathol; 1992 Jun; 19(3):172-80. PubMed ID: 1401342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanocytic lesions: selected problem areas.
    Wick MR; Patterson JW
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S52-83. PubMed ID: 16468418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.